What to know
- Presentation Day/Time: Tuesday, April 22, 1:20–2:45 pm
- Presenter: Jelonia Rumph, PhD, EIS officer assigned to the National Center for Environmental Health, Division of Environmental Health Science and Practice
What did we do?
- On May 31, 2024, CDC was alerted to an outbreak of illness potentially associated with Diamond ShruumzTM (DS) microdosing products, including chocolate bars, gummies, and cones, marketed as containing a proprietary mushroom blend. We analyzed data on reported cases to estimate the size of the outbreak and investigate associations between specific products and severe health effects.
What did we find?
- A total of 180 cases were reported by 34 states;
- 73 cases were hospitalized,
- 38 cases were admitted to the ICU, and
- 29 cases were intubated.
- 73 cases were hospitalized,
- Those who consumed DS bars had higher odds than those who consumed other products of experiencing hospitalization (OR: 2.3; 95% CI: 1.1–4.8), ICU admission (OR: 4.2; 95% CI: 1.5–12.0), and intubation (OR: 5.7; 95% CI: 1.6–20.1).
- Among those who consumed DS bars, the proportion hospitalized, admitted to ICU, and intubated increased with increasing amount consumed (P-Trend: 0.0237, 0.0035, and 0.008, respectively).
Why does it matter?
- This outbreak affected approximately 200 persons nationwide, suggesting that some microdosing products, particularly DS bars, may cause moderate/major health effects.
- Public health messaging about the risks for consuming microdosing products should be provided to consumers.
Abstract Category: Microdosing Products